Activity 3B. Mechanism of Action of HIV PrEP Medications PDF Share Learning Objective Performance Indicators List the four medications approved by the U.S. Food and Drug Administration (FDA) for HIV PrEP Explain the indications, dosing, and formulations, for FDA-approved HIV PrEP medications Discuss the issues and recommendations for HIV PrEP usage in persons with renal impairment Describe on-demand (2-1-1) HIV PrEP Summarize the multiple factors to consider when choosing HIV PrEP medications for selected patients InstructionsWatch this brief video by Dr. David Spach on the Mechanism of Action of HIV PrEP Medications (8 minutes). NOTE: this video is in the process of being updated to include the mechanism of action for the capsid inhibitor lenacapavir.David H. Spach, MD Editor-in-Chief Professor of Medicine Division of Allergy & Infectious Diseases University of WashingtonDisclosuresNone Share by e-mail From:Enter your e-mail address To: Enter the e-mail address of the recipient Your Message: Check-On-LearningQuestionsThe Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.You must be signed in to customize your interaction with these questions.
